v3.26.1
CONSOLIDATED STATEMENT OF CASH FLOWS - USD ($)
$ in Thousands
12 Months Ended 36 Months Ended
Apr. 25, 2026
Apr. 26, 2025
Apr. 27, 2024
Apr. 25, 2026
Cash flows from operating activities        
Net income $ 102,911 $ 100,952 $ 124,636  
Adjustments to reconcile net income to cash provided by operating activities        
(Gain)/loss on disposal and impairment of assets (7,287) 1,998 1,101  
(Gain)/loss on sale of investments (377) (235) (1,199)  
Provision for doubtful accounts 463 851 511  
Depreciation and amortization 47,440 46,667 48,552  
Amortization of right-of-use lease assets 84,436 76,964 76,133  
Lease impairment/(settlement) 0 0 (1,175)  
Equity-based compensation expense 15,688 17,400 14,426  
Goodwill impairment 19,967 20,581 0  
Change in deferred taxes 18,263 5,116 (3,268)  
Change in receivables 1,365 (1,906) (16,811)  
Change in inventories 26,323 12,792 19,877  
Change in other assets (10,728) 8,701 10,303  
Change in payables 4,052 (2,066) (8,606)  
Change in lease liabilities (84,233) (78,609) (76,766)  
Change in other liabilities (14,177) (21,935) (29,587)  
Net cash provided by operating activities 204,106 187,271 158,127  
Cash flows from investing activities        
Proceeds from disposals of assets 26,083 412 4,972  
Capital expenditures (76,306) (74,280) (53,551)  
Purchases of investments (3,713) (6,990) (18,351)  
Proceeds from sales of investments 1,751 11,994 24,816  
Acquisitions (86,423) (29,525) (39,440)  
Net cash used for investing activities (138,608) (98,389) (81,554)  
Cash flows from financing activities        
Payments on finance lease liabilities (918) (663) (489)  
Payments for debt issuance costs (784) 0 0  
Holdback payments for acquisitions 0 0 (5,000)  
Stock issued for stock and employee benefit plans, net of shares withheld for taxes (4,227) 12,350 10,872  
Repurchases of common stock (47,270) (77,930) (52,773)  
Dividends paid to shareholders (37,947) (34,955) (32,665)  
Dividends paid to minority interest joint venture partners [1] 0 (1,414) (1,172)  
Net cash used for financing activities (91,146) (102,612) (81,227)  
Effect of exchange rate changes on cash and equivalents 412 1,081 (926)  
Change in cash, cash equivalents and restricted cash (25,236) (12,649) (5,580)  
Cash, cash equivalents and restricted cash at beginning of period 328,449 341,098 346,678 $ 346,678
Cash, cash equivalents and restricted cash at end of period 303,213 328,449 341,098 $ 303,213
Supplemental disclosure of non-cash investing activities        
Capital expenditures included in accounts payable $ 9,467 $ 7,234 $ 5,952  
[1] Includes dividends paid to joint venture minority partners resulting from the repatriation of dividends from our foreign earnings that we no longer consider permanently reinvested.